Established by subcutaneously injecting HNSCC cell lines with PYGL knocked down into female BALB/c nude mice, xenograft tumor model was applied to validate the function of PYGL to cisplatin resistance of HNSCC. This evidence concerns the gene PYGL and neoplasm.